PXS-4728 by Syntara for Sleep Disorders: Likelihood of Approval

PXS-4728 is under clinical development by Syntara and currently in Phase II for Sleep Disorders.

Doc’s Moral Character License Snub; ENT Gets 25 Years; Hospital Snooping Settlement

Missouri physician Brett Snodgrass, MD, is taking the Iowa Board of Medicine to court after it allegedly refused to give him a medical license due

June 23, 2023

NIH awards 5.4 million for genomics integration in learning health systems

The National Institutes of Health (NIH) is awarding $5.4 million in first-year funding to establish a new program that supports the integration of genomics into

September 23, 2024

Tufts’ new ingestible microbiome sampling pill completes preclinical trials

Significant progress has been made at Tufts University School of Engineering in the development of a small device, about the size of a vitamin pill,

June 14, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.